374 related articles for article (PubMed ID: 30400823)
1. A risk score system to timely manage treatment in Crohn's disease: a cohort study.
Pallotta N; Vincoli G; Pezzotti P; Giovannone M; Gigliozzi A; Badiali D; Vernia P; Corazziari ES
BMC Gastroenterol; 2018 Nov; 18(1):164. PubMed ID: 30400823
[TBL] [Abstract][Full Text] [Related]
2. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
[TBL] [Abstract][Full Text] [Related]
3. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L
J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive review and update on Crohn's disease.
Gajendran M; Loganathan P; Catinella AP; Hashash JG
Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
[TBL] [Abstract][Full Text] [Related]
5. How fast up the ladder? Factors associated with immunosuppressive or anti-TNF therapies in IBD patients at early stages: results from a population-based cohort.
Ott C; Takses A; Obermeier F; Schnoy E; Salzberger B; Müller M
Int J Colorectal Dis; 2014 Nov; 29(11):1329-38. PubMed ID: 25179426
[TBL] [Abstract][Full Text] [Related]
6. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort study.
Fumery M; Pariente B; Sarter H; Savoye G; Spyckerelle C; Djeddi D; Mouterde O; Bouguen G; Ley D; Peneau A; Dupas JL; Turck D; Gower-Rousseau C;
Dig Liver Dis; 2019 Apr; 51(4):496-502. PubMed ID: 30611597
[TBL] [Abstract][Full Text] [Related]
8. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
9. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.
Cosnes J; Bourrier A; Laharie D; Nahon S; Bouhnik Y; Carbonnel F; Allez M; Dupas JL; Reimund JM; Savoye G; Jouet P; Moreau J; Mary JY; Colombel JF;
Gastroenterology; 2013 Oct; 145(4):758-65.e2; quiz e14-5. PubMed ID: 23644079
[TBL] [Abstract][Full Text] [Related]
10. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
[TBL] [Abstract][Full Text] [Related]
11. Current diagnosis and management of Crohn's disease in China: results from a multicenter prospective disease registry.
Li Y; Chen B; Gao X; Hu N; Huang M; Ran Z; Liu Z; Zhong J; Zou D; Wu X; Ren J; Sheng J; Zheng P; Wang H; Chen M; Chen J; Xi P; Lu J; Handel M; Liu Y; Fan H; Qian J
BMC Gastroenterol; 2019 Aug; 19(1):145. PubMed ID: 31420025
[TBL] [Abstract][Full Text] [Related]
12. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
[TBL] [Abstract][Full Text] [Related]
13. Natural History of Crohn's Disease in Elderly Patients Diagnosed Over the Age of 70 Years: A Population-Based Study.
Fumery M; Pariente B; Sarter H; Charpentier C; Armengol Debeir L; Dupas JL; Coevoet H; Peyrin-Biroulet L; dʼAgay L; Gower-Rousseau C; Savoye G;
Inflamm Bowel Dis; 2016 Jul; 22(7):1698-707. PubMed ID: 27206018
[TBL] [Abstract][Full Text] [Related]
14. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
[TBL] [Abstract][Full Text] [Related]
15. Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn's Disease.
Lakatos PL; Sipeki N; Kovacs G; Palyu E; Norman GL; Shums Z; Golovics PA; Lovasz BD; Antal-Szalmas P; Papp M
J Crohns Colitis; 2015 Oct; 9(10):891-8. PubMed ID: 26188353
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
[TBL] [Abstract][Full Text] [Related]
17. Crohn's disease and smoking: is it ever too late to quit?
Lawrance IC; Murray K; Batman B; Gearry RB; Grafton R; Krishnaprasad K; Andrews JM; Prosser R; Bampton PA; Cooke SE; Mahy G; Radford-Smith G; Croft A; Hanigan K
J Crohns Colitis; 2013 Dec; 7(12):e665-71. PubMed ID: 23790611
[TBL] [Abstract][Full Text] [Related]
18. The importance of the Crohn's disease activity index in surgery for small bowel Crohn's disease.
Lee JS; Kim HJ; Cho HM; Lee KM; Kye BH
J Visc Surg; 2016 Nov; 153(5):339-345. PubMed ID: 27179763
[TBL] [Abstract][Full Text] [Related]
19. Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index.
Bodini G; Giannini EG; De Maria C; Dulbecco P; Furnari M; Marabotto E; Savarino V; Savarino E
Dig Liver Dis; 2017 Feb; 49(2):175-180. PubMed ID: 27864028
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic features of Crohn's disease associated with failure of medical treatment.
Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
